NXI Therapeutics

NXI Therapeutics Extends Pre-Seed Financing to ₣3.5M in Run-up to Larger Seed Financing

Kickfund joins group of investors including JFG Life Sciences Foundation, BaseLaunch and Venture Kick 18 June 2024 -- Basel, Switzerland -- NXI Therapeutics AG, developer of tomorrow’s disruptive immunotherapies by coronin 1 modulation, today announces the extension of a pre-Seed financing totalling to ₣3.5m. This financing extension comes in the run-up to a larger Seed financing...
Spitalstrasse 41 4056 Basel, Switzerland